bpc-157 nasal spray BPC-157? #bpc157 #peptides #bpc tb 500 and bpc 157

Reported Adverse Effects In the available case series and observational literature, the most commonly reported adverse effects include: Injection-site redness or mild induration in approximately 8 to 12% of users Transient nausea, most often associated with oral formulations or higher injectable doses Lightheadedness in a small number of patients shortly after injection (under 2% of reported cases) Vivid dreams or mild sleep changes, reported anecdotally by a subset of users with no clear mechanistic explanation No published human case reports as of July 2025 document serious organ toxicity, malignancy, or endocrine disruption attributable to BPC-157

The gap in the logic is the same one as with methionine: correcting a deficiency is not the same as producing weight loss in someone who is replete

Whatever you need, were here for you guys, so just keep them coming, and well keep answering

Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes